Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro
- PMID: 6972538
- PMCID: PMC319375
- DOI: 10.1073/pnas.78.4.2502
Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro
Abstract
Cytotoxic hybridomas were generated by polyethylene glycol-induced fusion of cytotoxic T lymphocytes (CTL) and BW5147 lymphoma cells. The CTL populations used for fusion were obtained from BALB/c (H-2d) mice primed with leukemia EL4 of C57BL/6 (H-2b) and restimulated either in vivo or in vitro. To circumvent possible CTL-mediated nonspecific lysis of BW5147 cells during fusion, the CTL were transiently inactivated by trypsin prior to fusion. Four cytolytically active hybridomas were obtained, cloned, and subcloned. Hybrid clones lysed all H-2b leukemic target cells tested but not lipopolysaccharide- or concavanalin A-stimulated C57BL/6 lymphoblasts or non-H2b target tumor cells. The mechanism of hybridoma-mediated killing of target cells in vitro appears to be similar to that of parental CTL, although some differences have been observed. The hybridomas appear to possess neither natural killing nor antibody-dependent cytolytic activity. Clones of hybrids propagated in culture for over 6 months without the addition of known external stimulus (i.e., independent of cell growth factor and antigen) exhibit specific lytic activity against H-2b tumor cells. Such autonomous hybridomas will provide a tool for studying the mechanism of CTL-mediated lysis and the nature of the CTL receptors.
Similar articles
-
Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion.J Immunol. 1983 Jul;131(1):50-6. J Immunol. 1983. PMID: 6190926
-
Specificity studies on cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis of monoclonal cytolytic T lymphocytes.J Exp Med. 1982 Apr 1;155(4):1050-62. doi: 10.1084/jem.155.4.1050. J Exp Med. 1982. PMID: 6174669 Free PMC article.
-
Hapten-specific cytotoxic T cell clones undergo somatic variation of their antigen recognition specificity.Eur J Immunol. 1986 Jun;16(6):631-9. doi: 10.1002/eji.1830160608. Eur J Immunol. 1986. PMID: 2424767
-
Anti-T3 antibody both activates and inhibits the cytotoxic activity of human T cell clones.Behring Inst Mitt. 1985 Aug;(77):30-8. Behring Inst Mitt. 1985. PMID: 3936472 Review.
-
A critical analysis of the T cell hybrid technique.J Immunol Methods. 1982 Aug 13;52(3):269-81. doi: 10.1016/0022-1759(82)90001-1. J Immunol Methods. 1982. PMID: 6752275 Review.
Cited by
-
Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.Mol Ther. 2014 May;22(5):1029-38. doi: 10.1038/mt.2014.28. Epub 2014 Feb 27. Mol Ther. 2014. PMID: 24572294 Free PMC article.
-
Induction of c-ets and c-fos gene expression upon antigenic stimulation of a T cell hybridoma with inducible cytolytic capacity.J Exp Med. 1987 Sep 1;166(3):810-5. doi: 10.1084/jem.166.3.810. J Exp Med. 1987. PMID: 3498003 Free PMC article.
-
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.J Immunol Res. 2016;2016:8941260. doi: 10.1155/2016/8941260. Epub 2016 May 22. J Immunol Res. 2016. PMID: 27314056 Free PMC article. Review.
-
Inducible functions in hybrids of a Lyt-2+ BW5147 transfectant and the 2C CTL line.Immunogenetics. 1992;36(5):283-93. doi: 10.1007/BF00215656. Immunogenetics. 1992. PMID: 1644447
-
Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.Cancer Metastasis Rev. 1984;3(2):143-69. doi: 10.1007/BF00047661. Cancer Metastasis Rev. 1984. PMID: 6386143 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources